CRISPR Therapeutics AG ( CRSP) - Stock Earnings
CRSP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
CRSP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -130.6 million USD | 864000 USD |
| 2026Q1 | -122.9 million USD | 1.5 million USD |
| 2026Q2 | -91.2 million USD | 10.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRSP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.6 million USD | 370.0 million USD |
| 2024 | -366.3 million USD | 35.0 million USD |
| 2025 | -581.6 million USD | 3.5 million USD |
| 2026 Est. | — | — |
CRSP
Price: $49.25
52 week price:
Earnings Per Share: -4.71 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.2 million
Ebitda: -23.2 millionMarket Capitalization: 5.3 billion